Terms: = Sarcomas AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Prognosis
58 results:
1. Primary breast rhabdomyosarcoma in a 17-year-old girl.
Singotia L; Haritha VS
J Cancer Res Ther; 2023 Oct; 19(7):2070-2071. PubMed ID: 38376322
[TBL] [Abstract] [Full Text] [Related]
2. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
[TBL] [Abstract] [Full Text] [Related]
3. Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.
Ding M; Ran X; Qian S; Zhang Y; Wang Z; Dong M; Yang Z; Wu S; Feng X; Zhang J; Zhu L; Niu S; Zhang X
Aging (Albany NY); 2023 Dec; 15(24):15360-15381. PubMed ID: 38180104
[TBL] [Abstract] [Full Text] [Related]
4. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
Wang W; Zhang D; Chang D; Li Y; Ren L
Mol Cell Probes; 2023 Feb; 67():101897. PubMed ID: 36740149
[TBL] [Abstract] [Full Text] [Related]
5. Single-cell sequencing reveals the landscape of the tumor microenvironment in a skeletal undifferentiated pleomorphic sarcoma patient.
Yuan LL; Chen Z; Qin J; Qin CJ; Bian J; Dong RF; Yuan TB; Xu YT; Kong LY; Xia YZ
Front Immunol; 2022; 13():1019870. PubMed ID: 36466840
[TBL] [Abstract] [Full Text] [Related]
6. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
7. The role of soluble CD80 in patients with soft tissue tumors.
Matsuyama Y; Asanuma K; Yoshida K; Hagi T; Iino T; Nakamura T; Sudo A
J Orthop Surg Res; 2022 Sep; 17(1):404. PubMed ID: 36064421
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.
Bhave P; Ahmed T; Lo SN; Shoushtari A; Zaremba A; Versluis JM; Mangana J; Weichenthal M; Si L; Lesimple T; Robert C; Trojanello C; Wicky A; Heywood R; Tran L; Batty K; Dimitriou F; Stansfeld A; Allayous C; Schwarze JK; Mooradian MJ; Klein O; Mehmi I; Roberts-Thomson R; Maurichi A; Yeoh HL; Khattak A; Zimmer L; Blank CU; Ramelyte E; Kähler KC; Roy S; Ascierto PA; Michielin O; Lorigan PC; Johnson DB; Plummer R; Lebbe C; Neyns B; Sullivan R; Hamid O; Santinami M; McArthur GA; Haydon AM; Long GV; Menzies AM; Carlino MS
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793872
[TBL] [Abstract] [Full Text] [Related]
9. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y
BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833
[TBL] [Abstract] [Full Text] [Related]
10. Cancer combination therapies by silencing of ctla-4, PD-L1, and TIM3 in osteosarcoma.
Sorkhabi AD; Sarkesh A; Fotouhi A; Saeedi H; Aghebati-Maleki L
IUBMB Life; 2022 Sep; 74(9):908-917. PubMed ID: 35638098
[TBL] [Abstract] [Full Text] [Related]
11. New Approaches Promise to Improve Local Ewing Sarcoma Results.
Cohen IJ; Ash S
J Pediatr Hematol Oncol; 2022 Aug; 44(6):280-284. PubMed ID: 35537008
[TBL] [Abstract] [Full Text] [Related]
12. Immunological and prognostic significance of novel ferroptosis-related genes in soft tissue sarcoma.
Zhao J; Zhao Y; Ma X; Feng H; Cui R
PLoS One; 2022; 17(1):e0262234. PubMed ID: 34982796
[TBL] [Abstract] [Full Text] [Related]
13. CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes.
Schroeder BA; LaFranzo NA; LaFleur BJ; Gittelman RM; Vignali M; Zhang S; Flanagan KC; Rytlewski J; Riolobos L; Schulte BC; Kim TS; Chen E; Smythe KS; Wagner MJ; Mantilla JG; Campbell JS; Pierce RH; Jones RL; Cranmer LD; Pollack SM
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34465597
[TBL] [Abstract] [Full Text] [Related]
14. A case of intracranial myxoid mesenchymal tumor with EWSR1:CREM fusion in an adult female: Extensive immunohistochemical evaluation.
Kambe A; Kuwamoto S; Shimizu T; Amisaki H; Sakamoto M; Inagaki H; Kurosaki M
Neuropathology; 2021 Aug; 41(4):315-323. PubMed ID: 34258808
[TBL] [Abstract] [Full Text] [Related]
15. Clinical, histopathological, and immunohistochemical studies of histiocytic sarcoma in four-toed hedgehogs (Atelerix albiventris): A retrospective study.
Makishima R; Kondo H; Shibuya H
J Vet Med Sci; 2021 Mar; 83(3):419-426. PubMed ID: 33390364
[TBL] [Abstract] [Full Text] [Related]
16. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor".
Cloutier JM; Charville GW; Mertens F; Sukov W; Fritchie K; Perry KD; Edgar M; Rowsey RA; Folpe AL
Mod Pathol; 2021 Apr; 34(4):758-769. PubMed ID: 33318583
[TBL] [Abstract] [Full Text] [Related]
17. An immunohistochemical analysis of CD3, PD-L1, and ctla-4 expression in carcinosarcomas of the gynecological tract and their metastases.
Karpathiou G; Chauleur C; Dal Col P; Dridi M; Hathroubi S; Mobarki M; Peoc'h M
Pathol Res Pract; 2020 Aug; 216(8):153028. PubMed ID: 32703493
[TBL] [Abstract] [Full Text] [Related]
18. NGS-analysis to the rescue: dual checkpoint inhibition in metastatic osteosarcoma - a case report and review of the literature.
Nuytemans L; Sys G; Creytens D; Lapeire L
Acta Clin Belg; 2021 Apr; 76(2):162-167. PubMed ID: 31635553
[No Abstract] [Full Text] [Related]
19. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract] [Full Text] [Related]
20. Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides.
Haap M; Wiefels J; Horger M; Hoyer A; Müssig K
Blood Rev; 2018 May; 32(3):225-234. PubMed ID: 29223447
[TBL] [Abstract] [Full Text] [Related]
[Next]
